{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-023048","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2025-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.894212+00:00","generated_at":"2026-05-18T04:58:35.057218+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"DiaMedica raises $30.1M via private placement of 8.6M shares at $3.50 to fund preeclampsia pipeline","bullets":["Private placement of 8,606,426 common shares at $3.50 per share, raising $30.1M gross proceeds.","Closing expected July 23, 2025; no placement agent engaged.","Proceeds to support DM199 IND submission and Phase 2b study for preeclampsia and fetal growth restriction.","Registration rights agreement requires filing resale registration statement within 10 business days of closing.","Transaction involves non-management related parties; exempt from Canadian MI 61-101 valuation/minority approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-023048","json":"https://secwatch.observer/filing/0001437749-25-023048.json","markdown":"https://secwatch.observer/filing/0001437749-25-023048.md","text":"https://secwatch.observer/filing/0001437749-25-023048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925023048/0001437749-25-023048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925023048/dmtp20250720_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:58:35.057218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}